+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn

+ Translate
+ Recently Requested

Potent inhibition of human 5-lipoxygenase and microsomal prostaglandin E₂ synthase-1 by the anti-carcinogenic and anti-inflammatory agent embelin

Potent inhibition of human 5-lipoxygenase and microsomal prostaglandin E₂ synthase-1 by the anti-carcinogenic and anti-inflammatory agent embelin

Biochemical Pharmacology 86(4): 476-486

Embelin (2,5-dihydroxy-3-undecyl-1,4-benzoquinone) possesses anti-inflammatory and anti-carcinogenic properties in vivo, and these features have been related to interference with multiple targets including XIAPs, NF?B, STAT-3, Akt and mTOR. However, interference with these proteins require relatively high concentrations of embelin (IC50 >4?M) and cannot fully explain its bioactivity observed in several functional studies. Here we reveal human 5-lipoxygenase (5-LO) and microsomal prostaglandin E2 synthase (mPGES)-1 as direct molecular targets of embelin. Thus, embelin potently suppressed the biosynthesis of eicosanoids by selective inhibition of 5-LO and mPGES-1 with IC50 =0.06 and 0.2?M, respectively. In intact human polymorphonuclear leukocytes and monocytes, embelin consistently blocked the biosynthesis of various 5-LO products regardless of the stimulus (fMLP or A23187) with IC50 =0.8 2?M. Neither the related human 12- and 15-LO nor the cyclooxygenases-1 and -2 or cytosolic phospholipase A2 were significantly affected by 10?M embelin. Inhibition of 5-LO and mPGES-1 by embelin was (I) essentially reversible after wash-out, (II) not impaired at higher substrate concentrations, (III) unaffected by inclusion of Triton X-100, and (IV) did not correlate to its proposed antioxidant properties. Docking simulations suggest concrete binding poses in the active sites of both 5-LO and mPGES-Because 5-LO- and mPGES-1-derived eicosanoids play roles in inflammation and cancer, the interference of embelin with these enzymes may contribute to its biological effects and suggests embelin as novel chemotype for development of dual 5-LO/mPGES-1 inhibitors.

(PDF emailed within 0-6 h: $19.90)

Accession: 055079325

Download citation: RISBibTeXText

PMID: 23623753

DOI: 10.1016/j.bcp.2013.04.015

Related references

Identification of 5-lipoxygenase and microsomal prostaglandin E2 synthase-1 as functional targets of the anti-inflammatory and anti-carcinogenic garcinol. Biochemical Pharmacology 77(9): 1513-1521, 2009

Structure-based discovery of inhibitors of microsomal prostaglandin E2 synthase-1, 5-lipoxygenase and 5-lipoxygenase-activating protein: promising hits for the development of new anti-inflammatory agents. Journal of Medicinal Chemistry 54(6): 1565-1575, 2011

Inhibition of microsomal prostaglandin E2 synthase-1 as a molecular basis for the anti-inflammatory actions of boswellic acids from frankincense. British Journal of Pharmacology 162(1): 147-162, 2011

Anti-inflammatory properties of prostaglandin E2: deletion of microsomal prostaglandin E synthase-1 exacerbates non-immune inflammatory arthritis in mice. Prostaglandins, Leukotrienes, and Essential Fatty Acids 89(5): 351-358, 2014

Inhibition of prostaglandin synthase by 6 11 di hydro di benzo b e thiepin 11 one 3 acetic acid a novel nonsteroidal anti inflammatory agent. Federation Proceedings 37(3): 662, 1978

Inhibition of prostaglandin generation in the rabbit brain in-vivo by AD-1590, a non-steroidal anti-inflammatory agent with potent antipyretic activity. Journal of Pharmacy and Pharmacology 37(12): 894-898, 1985

Hyperforin, an Anti-Inflammatory Constituent from St. John's Wort, Inhibits Microsomal Prostaglandin E(2) Synthase-1 and Suppresses Prostaglandin E(2) Formation in vivo. Frontiers in Pharmacology 2: 7, 2011

Prostaglandin H synthase-2 inhibitors interfere with prostaglandin H synthase-1 inhibition by nonsteroidal anti-inflammatory drugs. European Journal of Pharmacology 412(1): 101-108, 19 January, 2001

Differential inhibition of human prostaglandin endoperoxide synthase-1 and -2 by nonsteroidal anti-inflammatory drugs. Journal of Physiology and Pharmacology 48(4): 623-631, 1998

Microsomal prostaglandin E2 synthase-1 (mPGES-1): a novel anti-inflammatory therapeutic target. Journal of Medicinal Chemistry 51(14): 4059-4067, 2008

Anti-inflammatory role of microsomal prostaglandin E synthase-1 in a model of neuroinflammation. Journal of Biological Chemistry 286(3): 2331-2342, 2011

Inhibitors of microsomal prostaglandin E2 synthase-1 enzyme as emerging anti-inflammatory candidates. Medicinal Research Reviews 34(4): 825-855, 2015

Anti-inflammatory and analgesic activity of a novel inhibitor of microsomal prostaglandin E synthase-1 expression. European Journal of Pharmacology 620(1-3): 112-119, 2010

Esters of some non-steroidal anti-inflammatory drugs with cinnamyl alcohol are potent lipoxygenase inhibitors with enhanced anti-inflammatory activity. Bioorganic and Medicinal Chemistry Letters 25(22): 5028-5031, 2016

Recombinant human prostaglandin G/H synthase-1 and -2 Inhibition by non-steroidal anti-inflammatory drugs and biosynthesis of 15-hydroxy-eicosatetraenoic acid. Journal of Cellular Biochemistry Supplement 0(188): 318, 1994